 |
|
|
 |
|
Rationale:
- Probabilities of specific disease are affected by geographic area visited, type of travel, time of travel, type of food and
water ingested, and vaccination history.
- Yellow fever is not prevalent in Asia or India.
- Adventure travelers to the Rift Valley are more likely to acquire schistosomiasis or leptospirosis from fresh water contact
than are visitors to Nairobi, Kenya.
- Dengue is less likely to be acquired during the dry season, when mosquito transmission is markedly reduced.
- Enteric fever relatively unlikely in persons eating only cooked food and bottled water.
- The efficacy of yellow fever, hepatitis A and B vaccines makes these diseases unlikely if patient is vaccinated.
|
|
Evidence:
|
|
Comments:
- Rapid diagnostic tests for several diseases are often limited or not available.
- Malaria should always lead the list in the differential diagnoses of fever in travelers or immigrants who have been in an
endemic area within the previous 3 months. Although these persons often present with common ailments, physicians must be alert
to recognize and treat malaria to avoid a tragic outcome.
- Like malaria, several diseases are unlikely to be considered by physicians not well-acquainted with tropical diseases; are
seen with appreciable frequency among U.S. travelers returning from malarious areas; can present clinically within 2 months
of exposure; and may be serious or life-threatening if not treated with specific antibiotic drugs.
- Definitive diagnoses often rely on nonroutine methods of pathogen isolation or serologic testing that relies on serologic
comparisons of acute and convalescent (2 to 4 weeks later) antibody titers. For example, the diagnosis of dengue virus infection
in the U.S. requires that acute and convalescent serum samples be sent through state health departments to the CDC's Dengue Branch.
|
| FAQs |
|
|
|
Harry Tagbor, MBChB, DrPH, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Rick M. Fairhurst, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Thomas E. Wellems, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|